Shift shown in influenza A adamantane resistance [2]

JAMA

Volumn 296, Issue 13, 2006, Pages 1585-1586

  Shah, Raj C ^a  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMANTADINE; MEMANTINE; RIMANTADINE; ADAMANTANE; AMINO ACID RECEPTOR BLOCKING AGENT; ANTIVIRUS AGENT; SIALIDASE;

ALZHEIMER DISEASE; FOOD AND DRUG ADMINISTRATION; GENE MUTATION; HUMAN; IN VITRO STUDY; INFLUENZA VIRUS A; LETTER; PRESCRIPTION; PRIORITY JOURNAL; UNITED STATES; VIRUS RESISTANCE; ANTIBIOTIC RESISTANCE; DRUG EFFECT; INFLUENZA; NOTE; DRUG ANTAGONISM;

ADAMANTANE; ALZHEIMER DISEASE; ANTIVIRAL AGENTS; DRUG RESISTANCE, VIRAL; EXCITATORY AMINO ACID ANTAGONISTS; HUMANS; INFLUENZA A VIRUS; INFLUENZA, HUMAN; MEMANTINE; NEURAMINIDASE;

EID: 33749365744     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.296.13.1585-b     Document Type: Letter

References (3)

1. Bright RA, Shay DK, Shu B, Cox NJ, Klimov AI. Adamantane resistance among influenza A viruses isolated early during the 2005-2006 influenza season in the United States. JAMA. 2006;295:891-894.
2. Lipton SA. Paradigm shift in neuroprotection by NMDA receptor blockade: memantine and beyond. Nat Rev Drug Discov. 2006;5:160-170.
3. Forest Laboratories Inc. 2005 Annual Report. http://www.frx.com. Accessed May 3, 2006.